High-Throughput Experimentation for Medicinal Chemistry: State of the Art, Challenges, and Opportunities

Dipannita Kalyani(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael Wleklinski(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mycah R. Uehling(Merck & Co., Inc., Rahway, NJ, USA (United States))
ACS symposium series
November 15, 2022
Cited by 4


Related Papers